© RWD and Clinical Research Team - INAB | CERTH 2025
Impact of venetoclax-based therapies on autoimmune cytopenias in patients with chronic lymphocytic leukemia: a multicenter study conducted by ERIC, the European Research Initiative on CLL.
Principal Investigator(s): Marta Coscia
CD19 CAR-T cell therapy is effective in Richter transformation: a multicenter retrospective analysis by the European Research Initiative on chronic lymphocytic leukemia.
Principal Investigator(s): Ofrat Beyar-Katz
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.
Principal Investigator(s): Thomas Chatzikonstantinou
Central nervous system involvement in CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL.
Principal Investigator(s): Maya Koren-Michowitz
Clinical impact of clonal relationship in Richter transformation: an international multicenter study conducted by ERIC.
Principal Investigator(s): Riccardo Moia
Outcomes of patients with chronic lymphocytic leukemia that failed BTK inhibitor and venetoclax-based treatments, an international multicenter study conducted by ERIC.
Principal Investigator(s): Thomas Chatzikonstantinou
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL.
Principal Investigator(s): Alessandro Campanella
Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY.
Principal Investigator(s): Thomas Chatzikonstantinou
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Principal Investigator(s): Andrea Visentin
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL.
Principal Investigator(s): Darko Antic
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Principal Investigator(s): Thomas Chatzikonstantinou
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Principal Investigator(s): Lydia Scarfo
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Principal Investigator(s): Yair Herishanu
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Principal Investigator(s): Panagiotis Baliakas
A retrospective study screening CLL patients for mutations in NOTCH1, SF3B1, TP53, MYD88 and BIRC3 genes.
Principal Investigator(s): Panagiotis Baliakas
Principal Investigator(s): Panagiotis Baliakas, Kostas Stamatopoulos
© RWD and Clinical Research Team - INAB | CERTH 2025